DOSAGE REGIMEN FOR A COMBINATION THERAPY CONSISTING OFTCR-ENGINEERED T-CELLS IN COMBINATION WITH A PD-1 AXIS BINDING ANTAGONIST
Publication
EP4539874A1
Kind: A1
Mar 18, 2026
Applicants
USWM CT, LLC
Inventors
SARO, Jose, DAWE, Steve, GARCIA, Alejandro
IPC Classifications
A61K 39/00 20060101AFI20231222BHEP
A61P 35/00 20060101ALI20231222BHEP
A61K 35/17 20250101ALI20231222BHEP
A61K 39/395 20060101ALI20231222BHEP
C07K 16/28 20060101ALI20231222BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR